Document is current
Any future updates will be listed below
-
Authors
Leupe, Hannes https://orcid.org/0000-0001-9080-2370
Ahmadi Bidakhvidi, Niloefar
Goffin, Karolien
Van den Broeck, Bliede
Jentjens, Sander
Laenen, Annouschka
Pauwels, Elin
Lybaert, Willem
Van Cutsem, Eric
Bormans, Guy
Vandamme, Timon
Cleeren, Frederik
Dekervel, Jeroen
Geboes, Karen
Stroobants, Sigrid
Verslype, Chris
Deroose, Christophe M. https://orcid.org/0000-0002-6080-1577
-
Funding
Funding for this research was provided by:
Kom op tegen Kanker
- License Information
-
More Information
Article History
Received: 28 October 2024
Accepted: 29 March 2025
First Online: 15 May 2025
Declarations
:
: All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethische Commissie Onderzoek UZ/KU Leuven S63678) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study (NCT03883776).
: Informed written consent was obtained from all participants, with clear communication that the study's findings and data would be published in a scientific journal. All participants agreed to this condition.
: No conflicts of interest (CoIs) relevant to this work exist. Nonrelated potential CoIs include: CMD is/has been a consultant for (fees received by institution): Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, Terumo, PSI CRO, Immedica Pharma, Molecular Partners, Nuclear Research and consultancy. His institution has received travel fees from: GE Healthcare, Sirtex. Timon Vandamme received consultancy fees from AstraZeneca, Astellas, Bayer, Bristol Myers Squibb, Eisai, Elmedix, Ipsen, MyNeoTx, Nordic Pharma, Novartis, Roche, Sirtex, Servier, Takeda; research funding (institutional) from Ipsen and Novartis; support for travel/accomodation from Ipsen, AstraZeneca and Servier. KG received consultancy fees from Bayer, Novartis, Telix Pharmaceuticals, GE Healthcare, Lightpoint, Blue Earth Diagnostics, Merck Sharp & Dome, PSI CRO.
